Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study.

@article{Kakkar2010ExtendedPW,
  title={Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study.},
  author={Vijay Vir Kakkar and Jos{\'e} Luis Balibrea and J. Mart{\'i}nez-Gonz{\'a}lez and Paolo Prandoni},
  journal={Journal of thrombosis and haemostasis : JTH},
  year={2010},
  volume={8 6},
  pages={
          1223-9
        }
}
BACKGROUND There is not enough clinical evidence to make a strong recommendation on the optimal duration of thromboprophylaxis using low-molecular weight heparins (LMWH) in patients undergoing major cancer surgery. PATIENTS AND METHODS CANBESURE is a randomized, double-blind study which enrolled patients admitted for abdominal or pelvic surgery for cancer. They received 3500 IU of bemiparin subcutaneously once daily for 8 days and were then randomized to receive either bemiparin or placebo… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 74 CITATIONS, ESTIMATED 33% COVERAGE

Bemiparin in Oncology

VIEW 4 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

Incidence of pulmonary embolism in patients with newly diagnosed colorectal cancer

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Anti-tumor effects of bemiparin in HepG2 and MIA PaCa-2 cells.

VIEW 1 EXCERPT
CITES METHODS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2010
2019

CITATION STATISTICS

  • 4 Highly Influenced Citations

  • Averaged 8 Citations per year from 2017 through 2019